Study 16 of 19Erythropoietin (EPO) literatureNatureTop journal2026
Erythropoietin receptor on cDC1s dictates immune tolerance.
Not reported in abstract.
Where it sits
this study against the rest of the erythropoietin (epo) corpus4
Preclinical · this one
10
Observational
0
Open-label
2
Randomised
3
Reviews
Summary and findings
Not reported in abstract.
How much of this paper we could read: title only (0.00). The feed gave us little more than the title, so our summary is thin. This says nothing about the study's quality — read the source. What this means →
2026
Background
Not reported in abstract.
Methods
Not reported in abstract.
Results
Not reported in abstract.
Interpretation
Not reported in abstract.
Limitations
Not reported in abstract.
Elsewhere in the Erythropoietin (EPO) corpus
CEffects of erythropoietin on cardiac morphometry in exercised male and female adolescent rats.Veterinary research forum : an international quarterly journal · 2025 · Not reported in abstract.AnimalANon-Inferiority of Subcutaneous Efepoetin Alfa Compared to Methoxy Polyethylene Glycol-Epoetin Beta in Stage 3 or 4 CKD Patients: Insights From a Phase 3 Trial.Nephrology (Carlton, Vic.) · 2025 · Difference in response rates was 6.3% with 95% CI -3.1% to 15.5%.HumanAImpact of intravenous iron or exogenous erythropoietin on hemoglobin mass, exercise performance, and acute mountain sickness during altitude acclimatization.Journal of applied physiology (Bethesda, Md. : 1985) · 2025 · Absolute Hbmass (g) increased from SL and day 1 to day 13 (P < 0.0001).HumanDAn acetylated Tau-174 CSF biomarker discriminates between TDP-43 and tau pathology in patients with frontotemporal lobar degeneration.Nature medicine · 2026—DCasdatifan shows durable response linked to HIF-2α biology in kidney cancer.Nature · 2026—BThrombotic burden and longitudinal outcomes in Thai patients with polycythemia vera.Annals of medicine · 2026 · n=133 · 5-year overall survival was 82.7% (95% CI, 74.61-88.35).Human